FDA Inspection 1102782 — Integris BioServices LLC
The FDA completed an inspection of Integris BioServices LLC on June 13, 2019 in Olathe, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Olathe, KS (United States)
Additional Details
Bioanalytical BA/BE